Search

该计划为中美两国加快批准抗癌药物奠定了基础。

… Tuesday, December 22, 2020 总结 第 3 届年度 MSK-CTONG 研讨会通过线上的方式汇集了顶尖医学领域专家，包括学术性医师、来自制药和生物技术行业的科学带头人以及政府监管机构专家，共同探讨中美及国际临床试验。MSK 斯隆首席医生 Lisa DeAngelis 重申了 MSK 斯隆致力于支持和促进 MSK-CTONG 合作的机构承诺。澳大利亚第 26 任总理、亚洲学会第八届总裁兼 CEO 陆克文 (Kevin Rudd) 以英文和普通话发表了主题演讲，强调了中美合作共同抗击癌症的重要性。来自美国食品药品监督管理局 (FDA) 的 Richard Pazdur 博士和

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce Eileen M. O’Reilly, MD; Howard I. Scher, MD; and Deb Schrag, MD, MPH, have been elected to the 11th class of Giants of Cancer Care® for their contributions to gastrointestinal cancer care, genitourinary cancer care, and prevention and care delivery respectively.

… Thursday, May 4, 2023 Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce Eileen M. O’Reilly, MD ; Howard I. Scher, MD ; and Deb Schrag, MD, MPH , have been elected to the 11 th class of Giants of Cancer Care® for their contributions to gastrointestinal cancer care, genitourinary cancer

MSK researchers and collaborators have developed a new type of CAR T cell designed to attack a cell surface protein called uPAR — allowing them to target both tumors and cancer-supporting cells in the tumor microenvironment.

… Monday, March 30, 2026 Chimeric antigen receptor T-cell therapy — CAR T for short — has been a major advance in treating blood cancers like leukemia and lymphoma. But the immunotherapy has struggled against solid tumors for two main reasons: tumor cells often don’t share one consistent surface target

Atefeh “Atti” Riazi, Senior Vice President and Chief Information Officer of Memorial Sloan Kettering Cancer Center (MSK) has been selected as a recipient of the 2022 Health Information and Management System Society (HIMSS) Most Influential Women in Health IT Awards. 

… Monday, March 14, 2022 Atefeh “Atti” Riazi, Senior Vice President and Chief Information Officer of Memorial Sloan Kettering Cancer Center (MSK) has been selected as a recipient of the 2022 Health Information and Management System Society (HIMSS) Most Influential Women in Health IT Awards .  The award

Find out what Vice President Joe Biden had to say when he visited MSK for a roundtable “cancer moonshot” discussion.

… Friday, May 27, 2016 VIDEO From left: Roundtable participants Sue Posthumus, an MSK nurse; MSK President Craig Thompson; Vice President Joe Biden; Mary Solomon of ScanVan Mobile Mammography; and MSK neurosurgeon Mark Souweidane Video Details Summary MSK hosted the vice president and members of the New

Rosario Costas-Muñiz’s work is helping Latino patients at MSK and across Latin America.

… Friday, May 27, 2022 As a young girl growing up on the south side of Puerto Rico, Rosario Costas-Muñiz, PhD , felt a calling to help people with the mental health side effects of a cancer diagnosis. Today, she is a psycho-oncologist at Memorial Sloan Kettering Cancer Center. She focuses on the mental

El trabajo de Rosario Costas-Muñiz ayuda a pacientes latinos en MSK y en toda América Latina.

… Friday, May 27, 2022 Cuando era una niña y crecía en el lado sur de Puerto Rico, la doctora Rosario Costas-Muñiz , sintió el llamado de ayudar a las personas a lidiar con los efectos secundarios de un diagnóstico de cáncer en la salud mental. En la actualidad, es psicooncóloga en el Memorial Sloan Kettering

Craig B. Thompson, MD, has been named the new President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center effective November 2, 2010. His appointment concludes a search that began in January 2010.

… Tuesday, August 10, 2010 Craig B. Thompson, MD , has been named the new President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center effective November 2, 2010. His appointment concludes a search that began in January 2010. He succeeds Harold Varmus, MD, who left Memorial Sloan Kettering

Research recently published by MSK scientists suggests that the best way to fight dangerous bacteria may be with other bacteria.

… Tuesday, June 20, 2017 Summary People with cancer are particularly susceptible to infections because treatment often damages their immune system. Now research is suggesting that the best way to combat these dangerous infections may be with other, nonharmful bacteria. Highlights Antibiotics are an important

A new study by a team of 12 thoracic surgeons at Memorial Sloan Kettering Cancer Center (MSK), published recently in the Annals of Surgery,([i]) is the first to identify a comprehensive list of clinical factors significantly associated with referring patients with stage 1 NSCLC to SBRT.

… Tuesday, November 5, 2024 Minimally invasive surgery (MIS) and stereotactic body radiotherapy (SBRT) are both used to treat stage 1 non-small cell lung cancer (NSCLC). While MIS remains the standard of care for patients with operable disease, selecting which patients should be referred for SBRT has been